⌘K
Loading ticker…
Ionis Pharmaceuticals, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Ionis Pharmaceuticals, Inc. Common Stock (IONS) has a 3-month relative strength percentile of 57 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.0%, relative volume 2.10×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
57 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
IONS is held by 10 ETFs as of Mar 2026. Top owner: VTI at 0.02% weight, $375M notional. Top 3 carry $799M.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.02% | $375M |
| VBVanguard Small Cap ETF | 0.17% | $272M |
| VBKVanguard Small-Cap Growth ETF | 0.39% | $152M |
| VXFVanguard Extended Market ETF | 0.17% | $136M |
| XBIState Street SPDR S&P Biotech ETF | 1.14% | $85M |
| IWRiShares Russell Midcap ETF | 0.09% | $45M |
| IWFiShares Russell 1000 Growth ETF | 0.04% | $44M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.02% | $15M |
| IWBiShares Russell 1000 ETF | 0.02% | $8M |
| IWDiShares Russell 1000 Value ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IONS Jan avg: 0.72% median: 3.04% win: 75% σ: 6.54% n: 4 2022-04-12 → 2026-05-29 | IONS Feb avg: -4.94% median: -5.90% win: 25% σ: 7.43% n: 4 2022-04-12 → 2026-05-29 | IONS Mar avg: -5.28% median: -5.79% win: 0% σ: 3.83% n: 4 2022-04-12 → 2026-05-29 | IONS Apr avg: -2.34% median: -1.03% win: 20% σ: 3.61% n: 5 2022-04-12 → 2026-05-29 | IONS May avg: 3.50% median: 2.33% win: 60% σ: 9.38% n: 5 2022-04-12 → 2026-05-29 | IONS Jun avg: 11.61% median: 9.64% win: 100% σ: 12.97% n: 4 2022-04-12 → 2026-05-29 (current) | IONS Jul avg: 3.75% median: 2.62% win: 100% σ: 3.57% n: 4 2022-04-12 → 2026-05-29 | IONS Aug avg: 1.50% median: -1.80% win: 25% σ: 7.89% n: 4 2022-04-12 → 2026-05-29 | IONS Sep avg: 13.53% median: 8.33% win: 75% σ: 29.18% n: 4 2022-04-12 → 2026-05-29 | IONS Oct avg: 1.73% median: -1.23% win: 25% σ: 8.07% n: 4 2022-04-12 → 2026-05-29 | IONS Nov avg: 2.11% median: 2.21% win: 50% σ: 10.90% n: 4 2022-04-12 → 2026-05-29 | IONS Dec avg: -2.92% median: -3.26% win: 25% σ: 4.07% n: 4 2022-04-12 → 2026-05-29 |